Text Size

Long Term Effect of an Education and Training Program for Patients With Chronic Obstructive Pulmonary Disease

This study has been completed.
Sponsor:
Collaborator:
The Royal Norwegian Ministry of Health
Information provided by:
Norwegian University of Science and Technology
ClinicalTrials.gov Identifier:
NCT00159549
First received: September 8, 2005
Last updated: November 18, 2005
Last verified: November 2005
History of Changes
  Purpose

A parallell group study comparing the effect of an education program with an education and training program for patients with COPD. 30 participants in each group. Participants self-select which group they wanted to be in. Main outcome is SGRQ (a HQoL for patients with COPD).


Condition Intervention Phase
Chronic Obstructive Pulmonary Disease
 Behavioral: education and training program
 Phase 2
Phase 3

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Long Term Effect of an Education and Training Program for Patients With Chronic Obstructive Pulmonary Disease

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Norwegian University of Science and Technology:

Primary Outcome Measures:
  • St Geoprg Respiratory Questionnaire (SGRQ)

Secondary Outcome Measures:
  • COPD-Efficacy scale (Norwegian short version), Breathing Problems Questionnaire (BPQ), journal examinations, FVC, FEV1, six minutes walking test with registration of shortness of breath and pulseoxymetrical data.

Estimated Enrollment: 60
Study Start Date: January 2000
Estimated Study Completion Date: December 2005
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patients diagnosed with COPD (FEV1<75% of expected) who have the ability to conversation and active participation will be included.

Exclusion Criteria:

-

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00159549

Locations
Norway
Department of Community Medicine and General Practice
Trondheim, Norway, N-7489
Sponsors and Collaborators
Norwegian University of Science and Technology
The Royal Norwegian Ministry of Health
Investigators
Principal Investigator: Aslak Steinsbekk, PhD Norwegian University of Science and Technology
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00159549     History of Changes
Other Study ID Numbers: DMF 05/414
Study First Received: September 8, 2005
Last Updated: November 18, 2005
Health Authority: Norway: Norwegian Social Science Data Services

Keywords provided by Norwegian University of Science and Technology:
Patient education

Additional relevant MeSH terms:
Lung Diseases
Respiration Disorders
Pulmonary Disease, Chronic Obstructive
Lung Diseases, Obstructive
Respiratory Tract Diseases

ClinicalTrials.gov processed this record on May 23, 2013